Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 18, 2015 4:06 PM ET

Biotechnology

Company Overview of Visterra, Inc.

Executive Profile

Alan L. Crane

Co-Founder and Director, Cerulean Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 17 different industries.

See Board Relationships
51$37,500

Background

Mr. Alan L. Crane is the Co-Founder and President at Arsia Therapeutics, Inc. He is the Chairman of the Board at Arsia Therapeutics, Inc. Mr. Crane is a an Advisor at The Experiment Fund. Mr. Crane is a Partner and Entrepreneur at Polaris Partners. Mr. Crane focuses on building and investing in healthcare companies. He served as a Venture Partner at Polaris Partners since April 4, 2002 and also served as a General Partner. He focused on life sciences and healthcare companies. ...

Corporate Headquarters

One Kendall Square
Cambridge, Massachusetts 02139

United States

Phone: 617-498-1070
Fax: 617-498-1073

Board Members Memberships

Former Director
Former Director
Director
Founder and Chairman
Director
Chairman
Founder and Chairman of the Board
Co-Founder, President, and Chairman
1999-N/A
Former Director
2001-2010
Former Director
2005-2008
Former Director
2006-Present
Co-Founder and Director
2007-Present
Director and Member of Compensation Committee
2009-2014
Former Director and Member of Compensation Committee

Education

BA
Harvard College
MBA 1992
Harvard Business School
Unknown/Other Education 1988
Harvard Medical School
MA 1986
Harvard Graduate School Of Arts And Sciences

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$22,565
Unexercisable Options$10,667
Total Number of Options$33,232

Total Compensation

Total Annual Cash Compensation$37,500
Total Calculated Compensation$37,500
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Visterra, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.